These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9653639)

  • 1. [The clinical picture and stability of non-cognitive symptoms in patients with Alzheimer's disease].
    Haupt M; Jänner M; Stierstorfer A; Kretschmar C
    Fortschr Neurol Psychiatr; 1998 May; 66(5):233-40. PubMed ID: 9653639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation and stability of noncognitive symptom patterns in patients with Alzheimer disease.
    Haupt M; Jänner M; Ebeling S; Stierstorfer A; Kretschmar C
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):323-9. PubMed ID: 9876960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Noncognitive symptoms in Alzheimer's disease. A study of 150 community-dwelling patients using a questionnaire completed by the caregiver].
    Derouesné C; Piquard A; Thibault S; Baudouin-Madec V; Lacomblez L
    Rev Neurol (Paris); 2001 Feb; 157(2):162-77. PubMed ID: 11283463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
    Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
    J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease.
    Shinagawa Y; Nakaaki S; Hongo J; Murata Y; Sato J; Matsui T; Tatsumi H; Akechi T; Furukawa TA
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):951-6. PubMed ID: 17299806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndromes of behavioural and psychological symptoms in mild Alzheimer's disease.
    Moran M; Walsh C; Lynch A; Coen RF; Coakley D; Lawlor BA
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):359-64. PubMed ID: 15065229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Components of behavioral pathology in dementia.
    Schreinzer D; Ballaban T; Brannath W; Lang T; Hilger E; Fasching P; Fischer P
    Int J Geriatr Psychiatry; 2005 Feb; 20(2):137-45. PubMed ID: 15660411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and psychological syndromes in Alzheimer's disease.
    Mirakhur A; Craig D; Hart DJ; McLlroy SP; Passmore AP
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1035-9. PubMed ID: 15481075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study.
    Engelborghs S; Maertens K; Nagels G; Vloeberghs E; Mariën P; Symons A; Ketels V; Estercam S; Somers N; De Deyn PP
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1028-37. PubMed ID: 16250064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychotic symptoms and Alzheimer's disease].
    Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P
    Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Cieslukowska A; Pufal A
    Med Sci Monit; 2008 Sep; 14(9):CR473-9. PubMed ID: 18758418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.